SCHEMBL6181056

SCHEMBL6181056

Cc1[nH]nc(C(F)(F)F)c1-c1ccc(F)c(C#N)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 4/20 0.39
IKBKB O14920 2/20 0.39
CNR2 P34972 1/20 0.38
SMO Q99835 1/20 0.37
CHUK O15111 2/20 0.37
PLK4 O00444 1/20 0.37
CHEK1 O14757 1/20 0.37
AURKA O14965 1/20 0.37
ROCK2 O75116 1/20 0.37
CHEK2 O96017 1/20 0.37
INSR P06213 1/20 0.37
CDK1 P06493 1/20 0.37
CSF1R P07333 1/20 0.37
PIM1 P11309 1/20 0.37
FGFR1 P11362 1/20 0.37
PRKACA P17612 1/20 0.37
FLT1 P17948 1/20 0.37
FGFR3 P22607 1/20 0.37
RPS6KB1 P23443 1/20 0.37
CDK2 P24941 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7355977 0.80 CNR2 (0.46) PGRCNR2FLT3ARCYP11B1
SCHEMBL17785914 0.78 IKBKB (0.48) IKBKBCHUKLRRK2
SCHEMBL1978512 0.73 CHEK1 (0.40) IKBKBCHUKCHEK1GSK3AGSK3B
SCHEMBL3080716 0.72 CYP11B1 (0.50) CHEK1CYP11B1CYP11B2
SCHEMBL3075671 0.72 AR (0.57) PGRCHEK1AR
SCHEMBL31308696 0.71 IKBKB (0.58) IKBKBCNR2CHUKCHEK1
SCHEMBL7560776 0.70 AKT2 (0.59) IKBKBCNR2CHUKPLK4CHEK1
SCHEMBL13183784 0.69 NOTUM (0.39) IKBKBCHUKCHEK1GSK3AGSK3B
SCHEMBL1411744 0.69 CNR2 (0.43) PGRCNR2KDRFLT3CYP11B1
SCHEMBL16894268 0.67 KIF11 (0.56) PGRSMOFLT3ARCYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1460996-A4 NOVEL-N-4-(1H-IMIDAZOL-1-YL)-2-FLUOROPHENYL]-3-(TRIFLUOROMETHYL)-1-H-PYRAZOLE-5-CARBOXAMIDES AS FACTOR XA BRISTOL MYERS SQUIBB CO (US) 2005-11-16 EP disclosed
EP-1460996-A2 NOVEL-N-4-(1H-IMIDAZOL-1-YL)-2-FLUOROPHENYL]-3-(TRIFLUOROMETHYL)-1-H-PYRAZOLE-5-CARBOXAMIDES AS FACTOR XA Bristol-Myers Squibb Company (US) 2004-09-29 EP disclosed
WO-2003047517-A2 NOVEL-N-[4-(1H-IMIDAZOL-1-YL)-2-FLUOROPHENYL]-3-(TRIFLUOROMETHYL)-1-H-PYRAZOLE-5-CARBOXAMIDES AS FACTOR XA BRISTOL-MYERS SQUIBB COMPANY (US) 2003-06-12 WO disclosed
EP-0946508-A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS Du Pont Pharmaceuticals Company (US) 1999-10-06 EP disclosed
WO-1998028269-A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1998-07-02 WO disclosed